期刊文献+

参麦注射液对心衰犬地高辛肾排泄影响的实验研究 被引量:1

Effects of Shenmai Injection on the digoxin urinary excretion in the model dogs with heart failure
原文传递
导出
摘要 目的:参麦注射液对心衰犬地高辛肾排泄的影响。方法:将造模成功4周后的心衰犬20只随机分为对照组和参麦注射液低、中、高剂量组,每组5只。予地高辛注射液7.41μg/kgivst后,立即予对照组生理盐水20mlivqd×5,低、中、高剂量组分别予参麦注射液0.517、1.034、1.551ml/kg(均用生理盐水稀释至20ml)ivqd×5。于给药后24h、48h、72h、96h收集每日尿液计量,留取尿样4ml;用高效液相色谱-质谱联用法检测尿液地高辛浓度。结果:与对照组及3种剂量参麦注射液之间比较,对地高辛的肾排泄均未见显著影响,但低剂量组的尿地高辛累积排泄量与累积排泄率有高于对照组和中、高剂量组的趋势(P>0.05)。结论:参麦注射液对地高辛肾排泄无明显影响。 Objective:To clarify the effect of Shenmai Injection(SMI)on digoxin (DG) urinary excretion in model dogs with heart failure.Method:Twenty model dogs with HF were randomly divided into 4 groups:the control one and the low,middle and high dose ones of SMI (n=5).After digoxin injection 7.41 μg/kg iv st,the control group was administrated with 0.9% NaCl injection 20ml iv qd ×5d,and the 3 trial ones of different dose were done with SMI 0.517,1.034 and 1.551 ml/kg,diluted to 20ml with 0.9% NaCl injection,iv qd ×5d.The urine samples were collected at 24h,48h,72h and 96h after the administration.The digoxin concentration of urine was determined by LC/MS/MS.Result:The four groups had no significant difference in urinary excretion amount,accumulative urinary excretion amount,urinary excretion rate and accumulative urinary excretion rate.The low dose group showed only a tendency of increasing the accumulative urinary excretion amount and accumulative urinary excretion rate(P0.05).Conclusion:SMI has no significantly effect on DG urinary excretion.
出处 《中药药理与临床》 CAS CSCD 北大核心 2010年第3期6-8,共3页 Pharmacology and Clinics of Chinese Materia Medica
基金 国家自然科学基金资助项目(NO.30371752)
关键词 参麦注射液 心力衰竭 地高辛 药代动力学 Shenmai Injection digoxin heart failure urinary excretion
  • 相关文献

参考文献4

二级参考文献15

  • 1方云祥,李灿,王志纯,彭军.人参总皂甙对犬冠脉流量和血液动力学的影响[J].湖南医科大学学报,1995,20(1):5-8. 被引量:51
  • 2史成章,梁红萍,宋分科.参麦注射液对重症肝炎患者血液流变学的影响[J].中国危重病急救医学,1997,9(5):314-315. 被引量:21
  • 3Jardin F,Farcot JC,Boisante L,et al.Influence of positive end-expiratory pressure on left ventricular performance.N Engl J Med,1981,304:387-392.
  • 4Cassidy SS,Ramanathan M.Dimensional analysis of the left ventricle during PEEP: relative septal and lateral wall displacements.Am J Physiol,1984,246(6 Pt 2):H792-805.
  • 5Zwissler B,Forst H,Messmer K.Influence of positive end-expiratory pressure ventilation (PEEP) on left ventricular pattern of contraction in experimental ARDS.Eur J Med Res,1998,12:231-240.
  • 6Cao T,Yuan L,Duan Y.Mechanism study of rispiration-related hemodynamics using in vitro and in vivo models.Circulation,2003,108:1035.
  • 7Hoffmann B,Jepsen M,Hachenberg T,et al.Cardiopulmonary effects of non-invasive positive pressure ventilation (NPPV)-a controlled,prospective study.Thorac Cardiovasc Surg,2003,51:142-146.
  • 8Denault AY,Gorcsan J 3rd,Pinsky MR.Dynamic effects of positive-pressure ventilation on canine left ventricular pressure-volume relations.J Appl Physiol,2001,91:298-308.
  • 9Michard F,Teboul JL.Using heart-lung interactions to assess fluid responsiveness during mechanical ventilation.Crit Care,2000,4:282-289.
  • 10Brower R,Wise RA,Hassapoyannes C,et al.Effects of lung inflation on lung blood volume and pulmonary venous flow.J Appl Physiol,1985,58:954-963.

共引文献27

同被引文献37

  • 1毛静远,王强,魏广力,徐昕,王恒和,赵志强,张其梅,常延平,张运,郭永铁.生脉注射液对心衰大鼠地高辛组织浓度的影响[J].中国实验方剂学杂志,2006,12(11):33-35. 被引量:2
  • 2毛静远,魏广力,王恒和,赵志强,王强,张运,李红,常延平,吴慧轩,张其梅,虞东玲,郑颖,张宇.生脉注射液对心力衰竭患者地高辛肾排泄的影响[J].上海中医药大学学报,2006,20(3):20-23. 被引量:4
  • 3赵志强,毛静远,王恒和,魏广力,王强,张运,常延平,吴慧轩,张其梅,虞东玲,郑颖,张宇.生脉注射液对心力衰竭患者尿量的影响[J].中药材,2006,29(9):999-1002. 被引量:1
  • 4王强,魏广力,徐昕,王恒和,毛静远,赵志强,王占武,张其梅,常延平,张运.生脉注射液对心衰大鼠地高辛血药浓度的影响[J].中药药理与临床,2006,22(6):1-2. 被引量:3
  • 5毛静远,魏广力,王恒和,葛永彬,李彬,王怡,王贤良,郭永铁.不同剂量参附注射液对心衰大鼠地高辛血药浓度及相关药动学参数的影响[J].上海中医药大学学报,2007,21(4):58-60. 被引量:5
  • 6毛静远,李国政,崔小磊,等.中医药治疗心力衰竭用药规律的文献研究[C]//中华中医药学会心病分会,中华中医药学会心病分会第十次全国中医心病学术年会暨吉林省中医药学会心病第二次学术会议论文精选,2008:269-276.
  • 7Tsai HH,Lin HW,Lu YH,et al . A review of potential harmful in-teractions between anticoagulant/antiplatelet agents and Chi-nese herbal medicines[J]. PLoS One,2013,8(5) :e64255.
  • 8Tachjian A* Maria V,Jahangir A. Use of herbal products and po-tential interactions in patients with cardiovascular diseases[J]. JAm Coll Cardiol,2010,55(6):515-525.
  • 9Izzo AA,Di Carlo G,Borrelli F, et al. Cardiovascular pharmaco-therapy and herbal medicines:The risk of drug Interaction[J]. IntJ CardioU2005,98(1):1 -14.
  • 10Zick SM,Blume A, Aaronson KD. The prevalence and pattern ofcomplementary and alternative supplement use in individualswith chronic heart failure[J]. J Card Fail,2005,11 (8) :586-589.

引证文献1

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部